MyAverix Finance
US · Healthcare
Santhera Pharmaceuticals Holding AG (SPHDF)
Biotechnology
Santhera Pharmaceuticals Holding AG (SPHDF) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $275.50M, P/E ratio is 18.00, net margin is -133.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for SPHDF
Santhera Pharmaceuticals Holding AG (SPHDF) — FAQ
What is Santhera Pharmaceuticals Holding AG's market cap?
Santhera Pharmaceuticals Holding AG (SPHDF) has a reported market cap of $275.50M (data as of 2026-03-30).
What is SPHDF's P/E ratio?
The price-to-earnings (P/E) ratio for Santhera Pharmaceuticals Holding AG (SPHDF) is 18.00 (data as of 2026-03-30).
Does Santhera Pharmaceuticals Holding AG pay a dividend?
Dividend yield is not available in the current snapshot for Santhera Pharmaceuticals Holding AG (SPHDF). Check the MyAverix Finance app for the latest dividend data.
What sector is Santhera Pharmaceuticals Holding AG in?
Santhera Pharmaceuticals Holding AG (SPHDF) is classified in the Healthcare sector (Biotechnology industry).
What exchange is SPHDF listed on?
SPHDF is listed on US.
What is Santhera Pharmaceuticals Holding AG's net margin?
Santhera Pharmaceuticals Holding AG (SPHDF) reports a net margin of -133.7% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.